Karessa Pharma Holding AB | |
Stock Exchange | First North Sweden |
EPS |
SEK1.41 |
Market Cap |
SEK56.76 M |
Shares Outstanding |
11 M |
Public Float |
- |
Address |
Lahällsvägen 48 Täby AB 183 30 Sweden |
Employees | - |
Website | http://www.karessa.se |
Updated | 09/14/2018 |
Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its projects include K-01, K-02, and K-03. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Täby, Sweden. |